medigraphic.com
Órgano Oficial de la Asociación Mexicana de Hepatología

2005, Number 3

<< Back Next >>

Ann Hepatol 2005; 4 (3)

Intraoperative US-guided large volume ethanol injection for hepatocellular carcinoma greater than 4 cm

Mondragón-Sánchez R, Garduño-López AL, Gómez-Gómez E, Frias-Mendivil M, Mondragón-Sánchez A, Bernal-Maldonado R

Language: English
References: 17
Page: 200-203
PDF size: 56.81 Kb.


Text Extraction

Background: Percutaneous ethanol injection has been successfully used for hepatocelular carcinomas (HCC) smaller than 5 cm in size. For larger lesions large volume ethanol injection has not been well explored. Aim: Evaluate the results of intraoperative Ultrasonographic-guided large volume ethanol injection for HCC larger than 4 cm in size. Patients and methods: Ten patients were candidates for this treatment between June 1999 and July 2003. A retrospective review of the clinical files was performed. Absolute ethanol, average of 100 mL (range 80-120 mL) was administered intraoperatively. Follow-up evaluation included alpha-fetoprotein (AFP) and ultrasound or computed tomography. Results: There were six women and four men, the median age was 62 years (range 56-80). The median lesion size was 8 cm (range 4-15 cm). Hepatitis C liver cirrhosis was the most common associated chronic liver disease (70%). A significant reduction of AFP levels after treatment was observed (Initial 966 ng/dL, post treatment levels: 42 ng/dL) US and CT scan showed tumor necrosis. Morbidity was 40%. No operative mortality was recorded. The one and four year survival rate was 60% and 20%. Conclusion: Intraoperative US-guided large volume ethanol injection is a safe palliative therapy for cirrhotic patients with HCC lesions greater than 5 cm in size. The impact on survival should be compared in a controlled double blind study.


REFERENCES

  1. Livraghi T, Festi D, Monti F, Salmi A, Vettori C. US-guided percutaneous alcohol injection of small hepatic and abdominal tumors. Radiology 1986; 161: 309-312.

  2. Williams R, Rizzi P. Treating Small Hepatocellular Carcinomas. N Eng J Med 1996; 334: 728-729.

  3. Schafer D, Sorrell M. Hepatocellular Carcinoma. Lancet 1999; 353: 1253-1257.

  4. Marcos-Alvarez A, Jenkins R, Washburn W, Lewis W, Stuart K, Gordon F, Kane R, Clouse M. Multimodality treatment of Hepatocellular carcinoma in a hepatobiliary Specialty Center. Arch Surg 1996; 131; 292-298.

  5. Mor E, Kaspa R, Sheirner P, Schwartz M. Treatment of Hepatocellular Carcinoma Associated with Cirrhosis in the Era of Liver Transplantation. Ann Intern Med 1998; 129: 643-653.

  6. Liu, Chin Leung, Fan Sheung-Tat. Nonresectional Therapies for Hepatocellular Carcinoma. Am J Surg l997; 173: 358-365.

  7. Douglas G, Rosove M, Shaked A, Busuttil R. Current treatment Modalities for hepatocellular Carcinoma. Ann Surg 1994; 219: 236-247.

  8. Okada S. Local Ablation Therapy for Hepatocellular Carcinoma. Seminars in Liver Disease 1999; 19: 323-328.

  9. Régimbeau J, Farges O, Shen B, Sauvanet A, Belghiti J. Is surgery for large hepatocellular carcinoma justified? J Hepatol 1999; 31: 1062-1068.

  10. Okuda, Kunio. Hepatocellular carcinoma. J Hepatol 2000; 32: 225-237.

  11. Usatoff V, Habib N. Hepatic malignancy: challenges and opportunities for the surgeon. J R Coll Surg Edinb 2000; 45: 99-109

  12. Bartolini F, Gianini A, Napoli P. Hepatocellular carcinoma and cirrhosis. A review of the relative incidence in a 25 year period in the Florence area. Hepato-Gastroenterol 1984; 21: 215-217.

  13. Cortes-Espinosa T, Mondragón-Sánchez R, Hurtado-Andrade H, Sánchez-Cisneros R. Hepatocellular Carcinoma and Hepatic Cirrhosis in Mexico: A 25 year Necroscopy Review. Hepato-Gastroenterol l997; 44: 1401-1403.

  14. Mondragón-Sánchez R, Ochoa-Carrillo FJ, Ruiz-Molina JM, Herrera-Goepfer R, Oñate-Ocaña L, Aiello-Crocifoglio V. Carcinoma hepatocellular. Experiencia en el Instituto Nacional de Cancerología. Rev Gastroenterol Mex 1997; 62: 34-40.

  15. Livraghi T, Benedini V, Lazzoroni S, Meloni F, Torzilli G, Vettori C. Long Term Results of Single session percutaneous Ethanol Injection in Patients with large Hepatocellular Carcinoma. Cancer 1998; 83(1): 48-57.

  16. Tapani E, Soiva M, Lavonen J, Ristakari S, Vehmas T. Complications following high-dose percutaneous ethanol injection into hepatic tumors. Act Radiol 1996; 37: 655-659.

  17. Khan K, Yatsuhashi H, Yamasaki M, Inoue O. Prospective analysis of risk factors for early intrahepatic recurrence of hepatocellular carcinoma following ethanol injection. J Hepatol 2000; 32: 269-278.




2020     |     www.medigraphic.com